Authors: Amardeep Udeshi, SVP, EVERSANA APAC; Ankit Kulshrestha, Senior Principal, EVERSANA APAC; Nishit Patadia, Engagement Manager, EVERSANA APAC
Are you curious about the latest trends and strategies in the dynamic world of pharmaceutical mergers and acquisitions? Discover how the M&A landscape has rebounded post-pandemic, with a remarkable 34% increase in spending in 2023. Learn about the strategic benefits and potential pitfalls of these high-stakes deals, and why big pharma is turning to M&A to fill capability gaps and expand into new therapeutic areas. Dive into real-world examples and expert insights that reveal the critical factors for successful M&A and licensing deals. Don’t miss out on this comprehensive analysis that could reshape your understanding of the pharma industry’s future!
